Frankfurt - Delayed Quote EUR

SkinBioTherapeutics plc (5KW.F)

0.0855 -0.0030 (-3.39%)
As of 9:17 AM GMT+2. Market Open.
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
132.0570
132.0570
74.7610
--
--
Cost of Revenue
46.8670
46.8670
29.4240
--
--
Gross Profit
85.1900
85.1900
45.3370
--
--
Operating Expense
3,049.2070
3,049.2070
2,760.3320
1,494.3530
1,620.0450
Operating Income
-2,964.0170
-2,964.0170
-2,714.9950
-1,494.3530
-1,620.0450
Net Non Operating Interest Income Expense
-8.8860
-8.8860
-10.1350
-0.9260
--
Pretax Income
-3,008.2380
-3,008.2380
-2,992.2230
-1,498.0340
-1,620.0420
Tax Provision
-174.0890
-174.0890
-199.6220
-65.0650
-119.9560
Net Income Common Stockholders
-2,835.1490
-2,835.1490
-2,792.6010
-1,432.9690
-1,500.0860
Diluted NI Available to Com Stockholders
-2,835.1490
-2,835.1490
-2,792.6010
-1,432.9690
-1,500.0860
Basic EPS
-0.02
-0.02
-0.02
-0.01
-0.01
Diluted EPS
-0.02
-0.02
-0.02
-0.01
-0.01
Basic Average Shares
164,713.0450
164,713.0450
156,780.2360
146,697.0330
128,083.4940
Diluted Average Shares
164,713.0450
164,713.0450
156,780.2360
146,697.0330
128,083.4940
Total Operating Income as Reported
-2,999.3520
-2,999.3520
-2,982.0880
-1,497.1080
-1,620.0420
Total Expenses
3,096.0740
3,096.0740
2,789.7560
1,494.3530
1,620.0450
Net Income from Continuing & Discontinued Operation
-2,835.1490
-2,835.1490
-2,792.6010
-1,432.9690
-1,500.0860
Normalized Income
-2,801.8108
-2,801.8108
-2,544.3786
-1,432.9690
-1,500.0860
Interest Expense
8.8860
8.8860
10.1350
0.9260
--
Net Interest Income
-8.8860
-8.8860
-10.1350
-0.9260
--
EBIT
-2,999.3520
-2,999.3520
-2,982.0880
-1,497.1080
-1,620.0420
EBITDA
-2,946.2730
-2,946.2730
-2,942.2810
-1,492.0530
-1,614.9420
Reconciled Cost of Revenue
46.8670
46.8670
29.4240
--
--
Reconciled Depreciation
53.0790
53.0790
39.8070
5.0550
5.1000
Net Income from Continuing Operation Net Minority Interest
-2,835.1490
-2,835.1490
-2,792.6010
-1,432.9690
-1,500.0860
Total Unusual Items Excluding Goodwill
-35.3860
-35.3860
-265.9660
--
--
Total Unusual Items
-35.3860
-35.3860
-265.9660
--
--
Normalized EBITDA
-2,910.8870
-2,910.8870
-2,676.3150
-1,492.0530
-1,614.9420
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0000
0.0001
Tax Effect of Unusual Items
-2.0478
-2.0478
-17.7436
--
--
6/30/2020 - 8/13/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade